Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disorder characterised by progressive weakness and sensory loss due to the immune-mediated destruction of myelin in peripheral nerves. It is clinically significant as it can lead to significant disability if untreated, often requiring immunotherapy for management. A key association is its potential link to other autoimmune conditions, such as lupus or rheumatoid arthritis, highlighting the need for comprehensive evaluation.

Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.